Aspiriant LLC’s Vanguard Total International Bond ETF BNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,321
Closed -$906K 321
2025
Q3
$906K Sell
18,321
-92
-0.5% -$4.54K 0.03% 153
2025
Q2
$912K Buy
+18,413
New +$906K 0.03% 154
2019
Q4
Sell
-109,363
Closed -$6.43M 203
2019
Q3
$6.43M Buy
109,363
+671
+0.6% +$39.1K 0.58% 34
2019
Q2
$6.23M Hold
108,692
0.52% 38
2019
Q1
$6.06M Sell
108,692
-361
-0.3% -$19.8K 0.5% 37
2018
Q4
$5.92M Buy
109,053
+8
+0% +$437 0.45% 39
2018
Q3
$5.95M Buy
109,045
+1
+0% +$55 0.51% 38
2018
Q2
$5.97M Buy
109,044
+284
+0.3% +$15.5K 0.51% 38
2018
Q1
$5.95M Buy
+108,760
New +$5.9M 0.52% 38
2017
Q4
Sell
-106,832
Closed -$5.83M 95
2017
Q3
$5.83M Buy
+106,832
New +$5.83M 0.49% 41

Other funds holding BNDX

Aspiriant LLC's BNDX Position: Q4 2025 in Review

Aspiriant LLC sold out of Vanguard Total International Bond ETF (BNDX) in Q4 2025, closing a stake of 18,321 shares — an estimated $906K sold.

Aspiriant LLC first reported a position in BNDX in Q3 2017 and held it in 10 quarters. The position peaked at $6.43M in Q3 2019. 1,076 funds tracked by Wall St. Rank hold BNDX as of Q4 2025.

  • Aspiriant LLC reported no remaining Vanguard Total International Bond ETF position as of Q4 2025 after selling out during the quarter.
  • Aspiriant LLC sold 18,321 Vanguard Total International Bond ETF shares in Q4 2025, an estimated $906K.
  • Aspiriant LLC first reported a position in Vanguard Total International Bond ETF in Q3 2017 and held it in 10 quarters.
  • Aspiriant LLC's Vanguard Total International Bond ETF position peaked at $6.43M in Q3 2019.
  • 1,076 funds tracked by Wall St. Rank held Vanguard Total International Bond ETF as of Q4 2025.

Based on Aspiriant LLC's 13F filing for Q4 2025, filed 20 Jan 2026.